Product NDC: | 0093-7149 |
Proprietary Name: | Azithromycin |
Non Proprietary Name: | Azithromycin Monohydrate |
Active Ingredient(s): | 200 mg/5mL & nbsp; Azithromycin Monohydrate |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-7149 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065419 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080922 |
Package NDC: | 0093-7149-31 |
Package Description: | 30 mL in 1 BOTTLE (0093-7149-31) |
NDC Code | 0093-7149-31 |
Proprietary Name | Azithromycin |
Package Description | 30 mL in 1 BOTTLE (0093-7149-31) |
Product NDC | 0093-7149 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Azithromycin Monohydrate |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20080922 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | AZITHROMYCIN MONOHYDRATE |
Strength Number | 200 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |